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FMRFamide; muscle force; cell specificity; basal tonus; isometric; peripheral modulation; synapse BIOLOGICALLY ACTIVE PEPTIDES mediate many types of signaling between cells such as autocrine, paracrine, endocrine, and synaptic signaling. Peptides play vital roles during all stages of development and underlie a multitude of physiological and behavioral processes (Geary and Maule 2010; Kastin 2013; Yew et al. 1999 ). There are ϳ50 identified neuropeptides in the human central nervous system (CNS) and several hundred in invertebrates (Hummon et al. 2006; Herlenius and Lagercrantz 2001) . Despite over half a century of investigation, it remains largely unknown why most vertebrate and invertebrate genomes encode such a large number of conserved peptides and their receptors. As molecular and genetic tools continue to develop, particularly in model murine and invertebrate systems, we are beginning to understand the function of small populations of cells and even individual cells within systems and how modulation of these cells can alter physiological and behavioral output (Bargmann 2012; Certel et al. 2010; Choi et al. 2011) . A growing body of literature exists to support the view that different modulators can act on different subsets of neurons to activate specific neural circuits and/or inhibit others and ultimately produce a specific behavioral outcome (HarrisWarrick and Johnson 2010; Harris-Warrick and Kravitz 1984; Marder and Calabrese 1996; Selverston 2010) . This concept of "neuron-specific" or "circuit-specific" modulation may help explain why the CNS contains so many neuropeptides.
Investigations of the mechanisms through which neuropeptides modulate and regulate behavior often focus on neural circuitry and sometimes overlook effects on muscle cells despite the fact that muscle performance is the final objective of the motor output pattern (Hooper et al. 2007 ; Morris and Hooper 2001) . This is understandable in studies of chordate twitch fibers where current dogma indicates that muscle impulses follow motor neuron impulses one to one so that the strength, duration, and speed of contraction are more easily predicted from the impulse pattern in the motor axons. Invertebrate muscles, however, integrate information from synaptic inputs differently because they are often innervated by multiple excitatory axons, sometimes receive inhibitory inputs, and, in many cases, contract in response to graded electrical signals or even in response to hormones (Atwood 1976; Atwood and Cooper 1995; Atwood et al. 1965; Peron et al. 2009 ). Among invertebrates, modulation of centrally generated motor patterns by neurotransmitters or hormones can be complemented by peripheral modulation at neuromuscular synapses and/or muscle fibers by the same or similar substances (Ormerod et al. 2013) . In crab hearts, for example, FLRFamide peptides act centrally to increase the rate and amplitude of contractions by altering the rate of bursts generated by the cardiac ganglion, and they act peripherally to augment excitatory junctional potentials (EJPs) and muscle contractions (Fort et al. 2007) . FLRFamides also act directly on crab stomatogastric ganglion to increase pyloric rhythm frequency and to evoke gastric mill activity, and they act peripherally to enhance EJPs and contractions in gastric mill muscles (Jorge-Rivera et al. 1998; Weimann et al. 1993) . Thus central and peripheral modulatory effects appear to be coordinated to produce physiologically appropriate changes in muscle performance.
Although there is a growing body of evidence to indicate that peptides and other modulators can act in a cell-specific manner on neurons, few studies have examined the possibility that peptidergic or aminergic modulators may also work in a cell-specific or tissue-specific manner on effector cells. Perhaps the best example is for octopamine, which increases relaxation rate and cAMP levels more strongly in regions of the locust extensor-tibiae muscle that contain the highest proportions of slow and intermediate muscle fibers (Evans 1985) . Likewise, in Drosophila larvae, octopamine increases EJP amplitude and nerve-evoked contractions more strongly in some muscle fibers than others (Ormerod et al. 2013 ). In the crab gastric mill, allatostatin 3 decreases the initial EJP amplitude and enhances facilitation in one muscle (gm6) without altering EJP amplitude or facilitation in another (gm4), and proctolin increases EJP amplitude in muscle gm4 but not muscle gm6 (Jorge-Rivera et al. 1998 ). It was not clear, however, whether the changes in initial EJP amplitude in these studies were caused by presynaptic or postsynaptic effects; changes in synaptic facilitation reflect presynaptic rather than postsynaptic mechanisms (Zucker 1989) . In lobster stomach muscles, GABA was found to decrease the amplitude of EJPs in some muscles (gm6a and gm9) but not in others (the p1 muscle; Gutovitz et al. 2001) . In crab opener muscle, DRNFLRFamide increased transmitter release from nerve endings of the fast excitatory axon but not the slow excitatory axon (Rathmayer et al. 2002) , but postsynaptic effects were not examined. This same peptide induced contractions in superficial extensor muscles of crayfish but not in deep extensor or superficial flexor muscles (Quigley and Mercier 1997) , but the possibility that DRNFLRFamide might augment contractions evoked by muscle depolarization was not examined. Thus, although peripheral modulation by neuropeptides can involve cell-specific effects on neurons, there is a conspicuous lack of evidence that neuropeptides exhibit such specificity on muscle cells.
Here, we examine the question of whether a neuropeptide can elicit cell-selective effects postsynaptically on individual muscle cells using D. melanogaster as a model system. The muscle cells of third-instar larvae are uniquely identifiable, and details of synaptic innervation of these cells have been wellcharacterized (Hoang and Chiba 2001) . We investigated the most abundant peptide encoded in the Drosophila dFMRF gene, DPKQDFMRFa, which has been isolated and purified from Drosophila tissue and is thought to be released as a neurohormone (Nambu et al. 1998; Nichols et al. 1999; White et al. 1986 ). Previous work showed that this peptide can increase transmitter release from motor neurons in a cellspecific manner (Dunn and Mercier 2005; Klose et al. 2010) and that it acts directly on muscle cells to elicit slow contractions (Clark et al. 2008; Milakovic et al. 2014) . We now present evidence that DPKQDFMRFa alters input resistance preferentially in some muscle cells and elicits stronger contractions in these cells. We also show that the peptide increases the amplitude of nerve-evoked contractions, that postsynaptic mechanisms contribute to this effect, and that the effect is stronger in some muscle cells than in others. These findings support the view that peripheral modulatory effects can be selective for individual muscle cells.
MATERIALS AND METHODS

Fly Stocks
D. melanogaster Canton-S (CS) flies, obtained from Bloomington Drosophila Stock Center (BDSC), were used for all control trials unless otherwise indicated. All flies were provided with commercial fly media (Formula 4-24 Instant Drosophila Medium, Plain, 173200), including dry yeast (Saccharomyces cerevisiae), and were reared at 21°C, constant humidity, on a 12:12-h light-dark cycle. To investigate effects of knocking down expression of the mRNA encoding the FMRFamide receptor (FR), a transgenic line containing a FR inverted repeat (FR-IR) downstream of an upstream activating sequence (UAS) was obtained from Vienna Drosophila RNAi Center (VDRC no. 9594). Three tissue-specific drivers were used to examine reduced FR expression: elav-Gal4 (BDSC), 24B-Gal4 (BDSC), and tubP-Gal4 (BDSC). elav-Gal4 was used for pan-neuronal expression of the UAS-FR-IR transgene (Luo et al. 1994; Sink et al. 2001) . 24B-Gal4 (Brand and Perrimon 1993; Luo et al. 1994 ) was used to express UAS-FR-IR in all larval somatic muscles (Schuster et al. 1996) . tubP-Gal4 is an insert on the third chromosome that is balanced over TM3, Sb and allows for ubiquitous expression of Gal4 (Lee and Luo 1999) .
Dissection
Wandering, third-instar larvae were used for all experiments. Larvae were collected from the sides of their culture vials and then placed immediately onto a dissecting dish containing a modified hemolymphlike (HL6) Drosophila saline (Macleod et al. 2002) Larvae were pinned dorsal side up at the anterior and posterior most parts of the larvae. A small incision was made along the dorsal midline, and the larvae were eviscerated. All nerves emerging from the CNS were severed, and the CNS, including ventral nerve cord and the right and left lobes, was removed, leaving long nerve bundles innervating the body-wall muscles. The body wall was pinned out, exposing the body-wall muscles. This preparation allowed recording EJPs, input resistance, and muscle contractions (Fig. 1) .
Electrophysiological Recordings
Compound EJPs were elicited by stimulating all severed abdominal nerves using a suction electrode connected to a Grass S88 stimulator via a Grass Stimulus Isolation Unit (Grass Technologies, Warwick, RI). Impulses were generated at 0.2 Hz. EJPs were recorded using sharp, glass microelectrodes containing a 2:1 mixture of 3 M potassium chloride-3 M potassium acetate. Signals were detected with an intracellular electrometer (model IE-210; Warner Instruments), viewed on a HAMEG oscilloscope, and sent to a personal computer via an analog-to-digital converter (Brock University, Electronics division). Signals were acquired and processed in digital format using custom-made software (Evoke; Brock University, Electronics division). Microsoft Excel was used for further analysis. The acquisition software detected the maximum amplitude of each EJP. For each trial, EJP amplitudes were averaged over 30-s time intervals (6 responses), and each 30-s average was plotted over the 15-min trial, generating 30 data points.
Solutions and dissection used during input resistance measurements were identical to those described above except that 10 M nifedipine was used where noted. A high-impedance bridge amplifier (NeuroData IR283A Intracellular Recording Amplifier; Cygnus Technology) was used to inject current and record voltage responses from single muscle cells using single, sharp intracellular electrodes containing 3 M potassium sulfate. Each muscle cell was injected with a series of currents (4, 6, 8, 10, and 12 nA) , and voltage responses were recorded. The current injection series was performed six times throughout a 15-min recording period at time points 1, 4, 6, 9, 11, and 15 min. To calculate the input resistance, current and voltage values were used to generate V vs. I curves, and the slope of each curve was calculated for each of the six time points per muscle cell. The values were divided by the initial slope value (time point 1) and expressed as a percentage of the initial value.
Force Recordings
In some experiments, where contractions were compared with and without ablating specific muscle cells (Fig. 7) , force was detected using a custom force transducer composed of four silicon wafer strain gauges (Micron Instruments, Simi Valley, CA) in full Wheatstone bridge configuration and mounted about the narrowest part of a polycarbonate beam (Ormerod et al. 2013; Paterson et al. 2010) . The transducer operates linearly between 1 N and 2 N and exhibited no temperature sensitivity between 10 and 30°C. Signals were detected and amplified using a differential amplifier (model 3000; A-M Systems, Carlsborg, WA) with no online filtering. All other force recordings were made using a Grass FT03 Force Displacement Transducer connected to a Grass MOD CP122A amplifier. Contractions were elicited using electrical stimuli from a Grass S48 stimulator, which delivered bursts of eight impulses at 32 Hz every 15 s.
All force recordings were made using 1.5 mM CaCl 2 . The force recordings depicted in Fig. 7 were conducted using the modified hemolymph-like saline HL3.1 (Stewart et al. 1994) , the standard physiological saline used in the laboratory where these trials were conducted. HL3.1 contained (in mM): 10 NaHCO 3 , 115 sucrose, 5 trehalose, 70 NaCl, 5 KCl, 4 MgCl, 5 HEPES, and 1.5 CaCl 2 (pH 7.2). There were no qualitative differences between the two salines with regard to the ability of the peptide to enhance contractions. We have also previously demonstrated that these two salines do not alter octopamine-induced enhancements of EJPs (Ormerod et al. 2013) . Larvae were dissected as described above for EJP recordings. To attach the larvae to the force transducer, a hook was made from fine dissection pins and placed onto the posterior end of the larvae, after which all remaining pins except the anterior pin were removed. In select trials, a fine-angled-tip dissecting knife was used to ablate selectively a subset of muscles in each of the hemisegments. Care was taken to avoid any damage to any other tissue in the larvae.
Passive changes in muscle force. Following dissection, the anterior dissection pin was replaced with the Grass FT03 Force Displacement Transducer (Grass Instrument, Quincy, MA) as described previously (Clark et al. 2008; Milakovic et al. 2014 ). Contractions were amplified using a MOD CP122A amplifier (Grass Telefactor, West Warwick, RI), digitized using DATAQ data acquisition (Model DI-145; DATAQ Instruments, Akron, OH), and viewed using WinDaq software (DATAQ Instruments). The recording dish had a volume of approximately 0.2-0.4 ml and was perfused continuously at a rate of 0.7 ml/min. Excess fluid was removed by continuous suction.
RT-qPCR. Specific details for RT-quantitative PCR (qPCR) are reported elsewhere (Milakovic et al. 2014) . Briefly, total RNA was isolated using Norgen's Total RNA Purification Kit (St. Catharines, Ontario, Canada), 500 ng of total RNA were reverse-transcribed with iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA), and SYBR Green qPCR SuperMix (Invitrogen) was added to cDNA and primers. Samples were amplified for 40 cycles in a thermocycler (Bio-Rad) for 5 min at 95°C, 15 s at 95°C, 90 s at 58°C, and 30 s at 72°C. Primer sequences have been reported previously (Milakovic et al. 2014) .
In situ hybridization. Whole dissected (see above) third-instar larvae were fixed in a 4% paraformaldehyde solution overnight. Prehybridization washes (5 ϫ 5 min in PBS, 1 ϫ 5 min in SSC) were followed by hybridization of the tissues samples with digoxigenin (DIG)-labeled sense and antisense probes overnight in a hybridization chamber at 60°C. Posthybridization washes (2 ϫ 5 min in SSC at 60°C, 1 ϫ 30 min in SSC ϩ 50% formamide at 60°C, 1 ϫ 5 min in SSC at 60°C). Subsequently, tissue was washed (4 ϫ 5 min in TBS, 1 ϫ 30 min in blocking solution) before incubation with anti-DIG fluorescein (4 h in 1:100 anti-DIG fluorescein-blocking solution). Before microscopy, tissues were washed (3 ϫ 5 min in TBS, 3 ϫ 1 min in distilled water). Tissue was imaged on confocal microscopy (Nikon series 1000). Intensity of fluorescence was quantified using ImageJ software (National Institutes of Health). For each sample, the perimeter of each of the 4 cells was outlined in ImageJ, and a region of interest within the perimeter was defined in each cell to compare fluorescent staining between the fibers. Care was taken to ensure that each region of interest represented Ͼ50% of fiber area in each optical Fig. 1 . Schematic representation of the Drosophila 3rd-instar larval semi-intact preparation used for intracellular and force recordings. Emphasis is placed on the subset of longitudinal muscle cells examined in this study, larval body-wall muscles (6, 7, 12, and 13; in gray). Each abdominal segment is innervating by a segmental nerve, shown as black lines originating from the ventral ganglion. In all experiments, the ventral ganglion was removed, and physiological saline was washed over the preparation. Right, top: a bridge circuit enabled the injection of a known series of currents (4, 6, 8, 10 , and 12 nA) across the membrane and recording of the voltage response. Right, middle: compound excitatory junctional potentials (EJPs) were recorded by stimulating all segmental nerve branches and intracellularly recording from 1 of the 4 cells of interest. Right, bottom: for some force recordings, a hook was place on the posterior end of the preparation and connected to the beam of a custom force transducer [full Wheatstone bridge circuit made of silicon wafers; see Ormerod et al. (2013) ]. Other force recordings and basal tonus were recorded using a Grass FT03 tension transducer and amplifier. 6/7b, Segmental nerve branch, motor neuron 6/7-Ib (Hoang and Chiba 2001); RP3, RP3 motor neuron (Hoang and Chiba 2001) ; V in , voltage in. section and that no superficial or deep layers interfered with the outlined area in any of the optical sections. To account for cell volume, we took a 50-image z-stack for each sample. The average pixel intensity for each cell over the 50-image stack was compared across the 4 cells. By setting the muscle cell with the greatest relative amount of transcript expression to 100, we obtained a quantitative measure of transcript expression between the 4 cells of interest (muscle cells 6, 7, 12, and 13).
Statistical Analyses
Statistical significance was assessed using SigmaPlot software. For comparisons within conditions, a one-way ANOVA was used if the data were normally distributed and the variance was homogenous. If these two conditions were not met, a comparable nonparametric test was used. For comparisons both within and between conditions, a two-way repeated-measures (RM) ANOVA or comparable nonparametric test was used (Fig. 2, C-F, and Fig. 3, A-D) . For Fig. 4 , B-E, Fig. 5, A and B, Fig. 6A, Fig. 7 , A-D, and Fig. 8A , to determine between-group differences (whether peptide application altered the parameter of interest), we averaged all time points for each trial into three bins, before peptide application, during application, and during the washout, and performed a one-way RM ANOVA. For Figs. 6B and 8B, we isolated averaged data points at the 8-min time point (3 min into peptide application) and performed a one-way ANOVA across all conditions. In all cases, if a significant difference was obtained, a Tukey (for ANOVA) or Dunn (for ANOVA on ranks) post hoc test was performed to establish specific differences. GraphPad software was used for generating dose-response curves in Figs. 2B, 4A, and 9B.
RESULTS
Input Resistance
Cell-specific effects of DPKQDFMRFa on muscle cells were first assessed by estimating input resistance (Fig. 2) . Input resistance was determined by measuring slope resistance six times during each 15-min recording session (at 1-, 4-, 6-, 9-, 11-, and 14-min time points). Resting membrane potential values are typically approximately Ϫ42 to Ϫ44 mV, and there is no statistical difference across the four fibers of interest (fiber 6: 44.5 Ϯ 9.2 mV; fiber 7: 42.5 Ϯ 9.5 mV; fiber 12: 42.3 Ϯ 8.9 mV; fiber 13: 44.1 Ϯ 9.4 mV; Kruskal-Wallis 1-way ANOVA on ranks, H ϭ 2.12, P ϭ 0.548). Input Fig. 2 . DPKQDFMRFa, a modulatory peptide in the fruit fly Drosophila melanogaster, significantly reduced input resistance in cells 6 and 7 but not in 12 and 13. A, top: current-voltage curve from muscle cell 6 before (SALINE) and after peptide application (10Ϫ6 DPKQDFMRFa). Bottom: representative voltage traces from muscle cell 6 in the presence of saline (Control) and in the presence of 10 Ϫ6 M DPKQDFMRFa (10 Ϫ6 M DPK) in response to a series of square, hyperpolarizing current pulses (4, 6, 8, 10, and 12 nA). B: dose-response curve taken from input resistance recordings in muscle cell 6. C and D: DPKQDFMRFa significantly reduced the input resistance in cells 6 and 7 both acutely after 1 min of application and after 4 min of application of DPKQDFMRFa. E and F: DPKQDFMRFa does not alter the input resistance in cells 12 and 13. In both cells, the effect was reversible following a saline washout. *P Ͻ 0.05 resistance values were typically in the range of 3-5 M⍀ ( Fig.  2A) . A dose-response curve was constructed using muscle cell 6. We avoided the possibility of desensitization completely by using a naïve preparation for each concentration. The EC 50 for the effect of DPKQDFMRFa on input resistance was 1.3 ϫ 10 Ϫ7 M (Fig. 2B) . Application of 1 ϫ 10 Ϫ6 M DPKQDFMRFa elicited a significant reduction in the input resistance of muscle cell 6 after 1 and 4 min of peptide application [24 Ϯ 8 and 26 Ϯ 7%, respectively; 2-way RM ANOVA, F ϭ 13.281, P Ͻ 0.001; Tukey post hoc, P Ͻ 0.05; Fig. 2C ] and in muscle cell 7 of 1 and 4 min of peptide application (14 Ϯ 5 and 18 Ϯ 6%; 2-way RM ANOVA, F ϭ 19.284, P Ͻ 0.001; Tukey post hoc, P Ͻ 0.05; Fig. 2D ). The input resistance returned to control values within 1 min of saline wash. Interestingly, DPKQDFMRFa did not elicit a significant change in input resistance in muscle cell 12 (2-way RM ANOVA, F ϭ 0.716, P ϭ 0.612; Fig. 2E ) or muscle cell 13 (2-way RM ANOVA, F ϭ 0.870, P ϭ 0.503; Fig. 2F ). Control recordings with no peptide application demonstrated stable input resistance values over the 15-min recording period. Thus DPKQDFMRFa modulated input resistance of muscle cells in a cell-specific manner. Clark et al. (2008) demonstrated that DPKQDFMRFa-induced contractions require extracellular calcium and are blocked by nifedipine and nicardipine, suggesting the involvement of calcium influx through L-type calcium channels. We, therefore, sought to determine whether the cell-specific reduction in input resistance showed a similar relationship to L-type channels. Coapplication of nifedipine with DPKQDFMRFa prevented the reduction in input resistance in cells 6 (2-way RM ANOVA, F ϭ 0.909, P ϭ 0.478; Fig. 3A ) and 7 (2-way RM ANOVA, F ϭ 1.598, P ϭ 0.165; Fig. 3B ) and resulted in no change in input resistance in cells 12 (2-way RM ANOVA, F ϭ 0.649, P ϭ 0.663; Fig. 3C ) and 13 (2-way RM ANOVA, F ϭ 0.620, P ϭ 0.685; Fig. 3D) . Thus it appears that DPKQDFMRFa-dependent reduction in input resistance in cells 6 and 7 requires L-type calcium channels.
EJPs
We next examined the implications of the cell-specific reduction in input resistance on compound EJPs in the larval body-wall muscles. Figure 4A , left, depicts representative EJP traces before and after application of 10 Ϫ6 M DPKQDFMRFa. At the stimulus frequency used (0.2 Hz), there was a gradual decrease in EJP amplitude over the recording period due to low-frequency synaptic depression (Fig. 4 , B-E, black diamonds) as reported previously in this preparation (Dunn and Mercier 2005) and at other arthropod synapses (Bruner and Kennedy 1970; Bryan and Atwood 1981) . Low-frequency depression occurred in all 4 muscle cells, and the degree of depression was not significantly different between them (1-way ANOVA, F ϭ 2.939, P Ͼ 0.05; Fig. 4 , B-E, black diamonds). A dose-response was constructed from recordings made from muscle cell 6. The EC 50 for the effect of DPKQDFMRFa on EJPs was 4.1 ϫ 10 Ϫ8 M (Fig. 4A, right) . At 1 ϫ 10 Ϫ6 M, DPKQDFMRFa increased EJP amplitude in all 4 muscle cells (muscle 6: 1-way RM ANOVA, F ϭ 9.578, P ϭ 0.008, Fig.  4B ; muscle 7: 1-way RM ANOVA, F ϭ 9.427, P ϭ 0.005, Fig.  4C ; muscle 12: 1-way RM ANOVA, F ϭ 13.703, P ϭ 0.003, Fig. 4D ; muscle 13: 1-way RM ANOVA, F ϭ 9.621, P ϭ 0.007, Fig. 4E ). The increase was ϳ40% in cells 6 and 7 and ϳ30% in cells 12 and 13 (3 min into peptide application; fiber 6: 43.5 Ϯ 3.4%; fiber 7: 38.2 Ϯ 6.5%; fiber 12: 31.0 Ϯ 3.7%; fiber 13: 27.2 Ϯ 2.7%). The increase in EJP amplitude peaked after ϳ3 min in all cells investigated, and saline washout following DPKQDFMRFa application resulted in a return to baseline values in all cases. Application of DPKQDFMRFa also decreased the time to peak of the EJP by 28 Ϯ 9% (paired t-test, t ϭ Ϫ10.710, P Ͻ 0.001) and decreased the decay time by 24 Ϯ 19% (paired t-test, t ϭ Ϫ11.229, P Ͻ 0.001) in cells 6 and 7. Such changes in EJP time course are fairly consistent with the drop in input resistance, which would shorten the time constant of the postsynaptic membrane. Since nifedipine prevented DPKQDFMRFa from decreasing input resistance in muscle cells 6 and 7, we next sought to determine whether L-type calcium channels might contribute to the potentiation of EJP amplitude. We used 1 ϫ 10 Ϫ7 M DPKQDFMRFa, which was very close to the EC 50 concentration for the reduction in input resistance. Since enhancement of EJPs by the peptide was similar between muscles 6 and 7 (Fig. 4, B and C) , and EJP enhancement was similar between muscles 12 and 13 (Fig. 4, D and E) , data were combined for these 2 cell pairs. Coapplication of nifedipine did not alter the enhancement of EJPs by the peptide in any of the muscle cells (fibers 12 and 13, Fig. 5A , 1-way ANOVA, F ϭ 0.183, P ϭ 0.682; fibers 6 and 7, Fig.  5B , 1-way ANOVA, F ϭ 0.028, P ϭ 0.871). The concentration of nifedipine used (1 ϫ 10 Ϫ5 M) was slightly higher than the IC 50 (3 ϫ 10 Ϫ6 M) previously reported to inhibit L-type channels in Drosophila muscle cells (Morales et al. 1999) . At 1 ϫ 10 Ϫ7 M, DPKQDFMRFa elicited a significantly larger increase in EJP amplitude in cells 6 and 7 than in 12 and 13 (increases at 8 min were 23.3 Ϯ 2.1% for 6 and 7 pooled and 11.3 Ϯ 1.9% for 12 and 13 pooled; 1-way ANOVA, F ϭ 35.723, P Ͻ 0.001; Fig. 5, A and B) . Knockdown of FR pre-and postsynaptically. To examine the contribution of the FR to the potentiation of EJPs, the UAS-RNA interference (RNAi)/Gal4 system was used to knockdown receptor expression presynaptically (in nerves), postsynaptically (in muscles), and ubiquitously (Fig. 6, A and B) . In control trials with CS larvae, 1 ϫ 10 Ϫ6 M DPKQDFMRFa increased EJP amplitude by 66 Ϯ 12%. Knocking down FR expression in muscle cells (24B-Gal4/UAS-FR-IR) appeared to cause a small reduction in the potentiation induced by DPKQDFMRFa, but the potentiation after 3 min of peptide application (53 Ϯ 9%; Fig. 6B ) was not significantly different from CS larvae or from 24B larvae at the same time point (69.1 Ϯ 14.0%; Fig. 6B ). Knocking down FR expression in nerves (Elav-Gal4/UAS-FR-IR) significantly reduced the DPKQDFMRFa-induced increase in EJP amplitude after 3 min of peptide application (23 Ϯ 7%; Fig. 6B ) compared with CS larvae and Elav controls at the same time point (59.4 Ϯ 15.5%; Kruskal-Wallis 1-way ANOVA on ranks, H ϭ 37.723, P Ͻ 0.001; Dunn post hoc analysis, P Ͻ 0.05; Fig. 6B ), but the peptide still elicited a significant increase in EJP amplitude compared with control trials with no DPKQDFMRFa application (P Ͻ 0.05). Knocking down the FR expression ubiquitously (tubP-Gal4/UAS-FR-IR) reduced the peptide-dependent increase in EJP amplitude to only 11 Ϯ 7%, which was significantly different from both CS and tubP control (tubPGal4/ϩ) larvae after 3 min of peptide application (66.5 Ϯ 13.6%; P Ͻ 0.05). None of the outcross control lines was significantly different from CS controls (percentage increases in EJP amplitude were as follows: tubP-Gal4/ϩ: 66.5 Ϯ 13.6; 24B-Gal4/ϩ: 69.1 Ϯ 14.0; Elav-Gal4/ϩ: 59.4 Ϯ 15.5).
We previously confirmed knockdown of the FR using qPCR to quantify expression in each of our lines (Milakovic et al. 2014) . Ubiquitous (tubP-Gal4/UAS-FR-IR) knockdown lines had the largest reduction in transcript levels, relative to wildtype controls, with ϳ90% reduction. Expression was reduced in muscle (24B-Gal4/UAS-FR-IR) and nerve (Elav-Gal4/UAS-FR-IR) knockdown lines by 77 and 60%, respectively.
Nerve-Evoked Contractions
To determine whether the peptide might enhance contractions to a greater degree in some muscle cells than others, an isometric force transducer was used to quantify changes in the amplitude of muscle contractions that were evoked using bursts of electrical stimuli applied every 15 s (8 stimuli at 32 Hz within each burst) to all the segmental nerves. This stimulus protocol is within the range of motor output patterns underlying contractions recorded from tethered larvae (Paterson et al. 2010 ). Muscle cells 6 and 7 contributed ϳ50% of the ventral longitudinal force generated by semi-intact preparations, and muscle cells 12 and 13 contributed ϳ30% (see representative traces in Fig. 7, top) , consistent with cellular volume/sarcomeric potential. To determine whether DPKQDFMRFa affected individual muscle cells to the same degree, we used cell ablation to eliminate selected pairs of muscle cells (either 6 and 7 or 12 and 13) that contribute to longitudinal force production and then compared the effects of the peptide on nerve-evoked contractions (Ormerod et al. 2013) . It is important to note that a large number of the longitudinal muscles (e.g., dorsal muscle cells 1-3 and 9 -11) that would typically contribute to larval peristalsis are also ablated during dissection, but all other cells were left intact for recording contractions unless we deliberately ablated them to assess their contribution to the force generated. There are 30 muscle cells per abdominal hemisegment, and cells other than 6, 7, 12, and 13 could contribute to longitudinal contractions and might even be modulated by the peptide. To distinguish the contribution of cells 6 and 7 (not 12 and 13), these fibers were ablated after the initial dissection, and contractions of these preparations were compared with Fig. 6 . DPKQDFMRFa-induced enhancement of EJPs is largely dependent on presynaptic FMRFa receptor (FR) expression. A: using the yeast transcription activator protein (Gal4)/upstream activating sequence (UAS) system to knockdown expression of FR separately in muscle and nerve and ubiquitously. Knocking down FR expression postsynaptically (MUSCLE) did not alter the ability of the peptide to enhance EJPs compared with wild-type (Canton-S, CS) controls. Knocking down FR expression presynaptically (NERVE) significantly reduced the peptide-induced enhancement of EJPs compared with controls. Last, knocking down FR expression ubiquitously (UBIQUITOUS) also significantly reduced the peptide-induced enhancement of EJPs compared with controls. B: EJP amplitude at 8 min for all control and knockdown lines illustrates the predominant role presynaptic FR expression has on DPKQDFMRFa-mediated increases in EJP. EJPs in both the nerve and ubiquitous (Ubiq) knockdowns are significantly reduced compared with CS controls, but the reduction is greater in the ubiquitous knockdown highlighted by a lack of statistical difference from no-peptide controls. DPKQDFMRFa-induced increases in EJP amplitude in all Gal4 driver lines were not statistically different from CS controls. *P Ͻ 0.05. RNAi, RNA interference.
control preparations that were identical in every respect except that no cells were ablated following the initial dissection. The difference between contractions of preparations with and without selected cell ablation indicates the contribution of the selected muscle fiber pair (6 and 7 or 12 and 13) to the contraction. Thus the longitudinal force production examined here does not provide a comprehensive depiction of forces involved in in vivo locomotion but, rather, highlights muscles of the ventral body wall, which contacts the animal's substrate.
In the absence of peptide, nerve-evoked contractions decreased to approximately 40 -60% of their initial amplitude during the 1st 5 min of stimulation and were relatively stable thereafter (Fig. 7, A-C, black diamonds ). This effect, described previously and termed "rundown," has been reported on several occasions Macleod et al. 2002; Ormerod et al. 2013; Stewart et al. 1994) . In sham-operated preparations with no muscle cells ablated (Fig. 7A) , application of 1 ϫ 10 Ϫ6 M DPKQDFMRFa after 5 min of stimulation increased nerve-evoked contractions to 126 Ϯ 8% of their initial amplitude, which was more than double the force generated in control trials at the same time point but with no peptide applied (57 Ϯ 8% of initial amplitude; 1-way RM ANOVA, F ϭ 11.210, P Ͻ 0.001; Tukey post hoc, P Ͻ 0.05; Fig. 7A ). In preparations with muscle cells 6 and 7 intact and 12 and 13 ablated (Fig. 7B) , the effect of the peptide was nearly identical to that observed in preparations with no ablation, increasing contractions to a level (132 Ϯ 16% of initial amplitude) that was more than double the value observed in control trials with no peptide (49 Ϯ 11%; 1-way RM ANOVA, F ϭ 14.759, P Ͻ 0.001; Tukey post hoc, P Ͻ 0.05; Fig. 7B ). When muscle cells 12 and 13 were left intact and 6 and 7 were ablated (Fig. 7C) , the effect of DPKQDFMRFa was reduced compared with intact preparations and to preparations with cells 12 and 13 ablated, but peptide application did cause a significant increase in force compared with controls with no peptide (92 Ϯ 15% of initial value compared with 54 Ϯ 10% for control trials; 1-way RM ANOVA, F ϭ 4.751, P ϭ 0.030; Tukey post hoc, P Ͻ 0.05; Fig. 7C ). Together, these results indicate that in addition to contributing more to total longitudinal force, muscle cells 6 and 7 also contribute more to the enhancement of contractile force induced by DPKQDFMRFa.
In an attempt to bypass nerve stimulation and examine direct effects of the peptide on the muscle cells, we applied the same impulse bursts to the muscle cells using extracellular wire electrodes (Fig. 7D ) as described elsewhere (Ormerod et al. 2013) . (No cell ablations were performed in these trials, and the stimulus intensity was decreased an order or magnitude from that used for nerve stimulation.) These preparations also showed rundown of contraction amplitude over the 1st 5 min, and subsequent application of 1 ϫ 10 Ϫ6 M DPKQDFMRFa enhanced contraction amplitude to 127 Ϯ 24% of initial value, which was not significantly different from the increase observed in nonablated preparations subjected to nerve stimulation.
We also assessed DPKQDFMRFa-induced changes in nerve-evoked contractions in the muscle, nerve, and ubiquitous FR knockdown lines to distinguish postsynaptic and presynaptic contributions to the effect of the peptide. To minimize the Fig. 7 . DPKQDFMRFa application enhanced evoked contractions in muscle cells 6 and 7 more than in muscle cells 12 and 13. A-D: evoked isometric contractions in 3rd-instar larvae exhibit physiological rundown during the recording period as previously described (Ormerod et al. 2013) . A: recordings from semi-intact preparations with no muscle ablation reveal that exogenous application of 10 Ϫ6 M DPKQDFMRFa induced a significant increase in the amplitude (AMPL) of evoked contractions. B: the amplitude of evoked contractions in preparations with cells 12 and 13 ablated (leaving 6 and 7 intact) were also significantly enhanced following the application of 10 Ϫ6 M DPKQDFMRFa. C: the peptide-mediated enhancement of evoked contraction in preparations with muscle cells 6 and 7 ablated (leaving 12 and 13 intact) were greatly attenuated compared with preparations with no ablation or preparations with cells 12 and 13 ablated. D: attempts to bypass nervous stimulation using direct stimulation of muscle cells also demonstrated a significant enhancement of contraction amplitudes. *P Ͻ 0.05. impact of rundown in these trials, we waited a sufficient amount of time (5-10 min) for force recordings to stabilize before starting the experimental procedures. This reduced rundown to Ͻ15% over the 15-min recording period (Fig. 8A , no-peptide application). Figure 8B shows the peptide-induced increase in force at 3 min of peptide application, which was at or near the maximal effect (Fig. 8A) . In CS flies, 1 ϫ 10 Ϫ6 M DPKQDFMRFa elicited a 59.3 Ϯ 10.9% increase in force compared with its no-peptide control. Knocking down expression of the FR in the nerve resulted in a significant reduction in the peptide-induced increase in force production compared with the control trials (35.8 Ϯ 7.3%; 1-way ANOVA, F ϭ 113.220, P Ͻ 0.001; Tukey post hoc, P Ͻ 0.05; Fig. 8B ). Reducing FR expression in muscle also caused a significant reduction in the peptide-induced increase in contractions compared with CS trials (29.0 Ϯ 9.7%; P Ͻ 0.05; Fig. 8B ). These results suggest that both presynaptic and postsynaptic receptors contribute to the ability of the peptide to enhance muscle contraction. Reducing FR expression ubiquitously also resulted in a significant reduction in the response to DPKQDFMRFa compared with CS (18.0 Ϯ 7.7%; P Ͻ 0.05; Fig. 8B ). The effects of the peptide on nerve-evoked contractions in CS larvae were not statistically different from any of the uncrossed driver lines (24B-Gal4, Elav-Gal4, and tubP-Gal4; P Ͼ 0.05; Fig. 8B ).
It is also noteworthy that the ability of the peptide to increase nerve-evoked contractions in preparations with no muscle cells ablated was qualitatively and quantitatively similar during rundown (Fig. 7A ) and after rundown (Fig. 8A, CS larvae) . The ability of DPKQDFMRFa to counteract the effects of rundown on contraction amplitude suggests that this peptide may play a role in sustaining contraction size.
Changes in Tonus
Previously, it has been demonstrated that DPKQDFMRFa elicits small, sustained muscle contractions in third-instar larvae through a direct action on muscle cells (Clark et al. 2008; Hewes et al. 1998; Milakovic et al. 2014) . To examine whether these peptide-induced contractions exhibit cell specificity, we assessed the effects of ablating pairs of muscle fibers (representative traces in Fig. 9A ). The EC 50 for peptide-induced contractions was 6.6 ϫ 10 Ϫ8 M as estimated from the dose-response curve (Fig. 9B) . To compare effects of DPKQDFMRFa on different muscle fibers, a concentration of 1 ϫ 10 Ϫ7 M was selected since this was slightly above the EC 50 value but below the maximal (saturating) effect (Fig. 9B ). This peptide concentration induced contractions in preparations with and without muscle ablation (Fig.  9C ). Contractions were reduced significantly by ablation of cells 6 and 7 or 12 and 13, and contractions were significantly smaller when 6 and 7 were ablated than when 12 and 13 were ablated (1-way ANOVA, F ϭ 39.194, P Ͻ 0.001; Tukey post hoc, P Ͻ 0.01; Fig. 9C ).
Receptor Distribution
Finally, we wanted to determine whether cell-specific differences in peptide responsiveness could be attributable to differences in FR expression. Initial attempts to design an antibody against the FR protein were unsuccessful, so we examined changes in transcript expression (representative image in Fig. 10A , and areas of the muscle we used for analysis are shown in Fig. 10B ). Muscle fiber 7 had the highest FR expression compared with the other three muscle fibers, so it was arbitrarily set to 100% (Fig. 10C ). Muscle fiber 6 had, on average, 90.5 Ϯ 6.8% expression compared with muscle 7. Muscle 12 showed 71.9 Ϯ 5.9% expression, and muscle 13 exhibited 52.2 Ϯ 6.0% expression relative to muscle 7. Expression levels in fibers 6 and 7 were not statistically different from one another (P Ͼ 0.05). Expression levels in fibers 12 and 13 were also not statistically different from one another (P Ͼ 0.05), but expression in fibers 6 and 7 was statistically different from expression in fibers 12 and 13 (Kruskal-Wallis 1-way ANOVA on ranks, H ϭ 39.487, P Ͻ 0.001; Tukey post hoc, P Ͻ 0.05; Fig. 10C ). Fig. 8 . Pre-and postsynaptic FR expression is required for DPKQDFMRFainduced increases in evoked contraction amplitude. A: using the Gal4/UAS system to knockdown expression of FR separately in muscle and nerve and ubiquitously. Knocking down FR expression presynaptically (NERVE) significantly reduced the 10 Ϫ6 M DPKQDFMRFa-induced enhancement of evoked contractions compared with controls. Knocking down FR expression postsynaptically (MUSCLE) also significantly reduced the peptide-induced enhancement of evoked contractions compared with wild-type (CS) controls. Knocking down FR expression ubiquitously (UBIQUITOUS) also significantly reduced the peptide-induced enhancement of evoked contractions compared with controls. B: evoked contraction amplitudes at 8 min for all control and knockdown lines. Peptide-induced increases in the amplitude of evoked contractions were significantly reduced in all 3 knockdown lines. Both the nerve and muscle knockdown lines were significantly different from no-peptides controls, and the ubiquitous knockdown was not significantly different from no-peptide controls. DPKQDFMRFa-induced increases in evoked contractions amplitude in all Gal4 driver lines were not statistically different from CS controls. *P Ͻ 0.05.
DISCUSSION
We provide evidence that a Drosophila neuropeptide, DPKQDFMRFa, elicits cell-selective effects on muscle fibers of third-instar larvae. DPKQDFMRFa induced a significant reduction in input resistance in muscle cells 6 and 7 but not in cells 12 and 13. EJP amplitude increased in all four muscle cells investigated, but the increase elicited by 1 ϫ 10 Ϫ7 M DPKQDFMRFa was significantly higher in fibers 6 and 7 than in 12 and 13. Knocking down FR expression separately in nervous and muscle tissue demonstrated that enhancement of EJP amplitude was largely dependent on presynaptic FR expression. Muscle-ablation experiments demonstrated that DPKQDFMRFa enhanced nerve-evoked contractions more strongly in muscle cells 6 and 7 than in cells 12 and 13. Contractions induced directly by the peptide were also larger in cells 6 and 7 than in 12 and 13. Finally, FR expression was significantly greater in cells 6 and 7 than in 12 and 13. Taken together, these results indicate that DPKQDFMRFa can elicit greater modulatory effects on some muscle cells than others. This preferential modulation, which we refer to as cell-selective, appears to involve differential expression of the receptor of the peptide.
A reduction in input resistance indicates increased cellular conductance and suggests the activation of ion channels in the plasma membrane, although enhanced activation of exchangers in the muscle membrane can have a comparable effect (Fritz et al. 1979; Walther and Zittlau 1998) . The ability of nifedipine to abolish the drop in input resistance suggests that DPKQDFMRFa might activate dihydropyridine-sensitive, L-type calcium currents known to be present in the plasma membrane of these muscle cells (Gielow et al. 1995) . However, such L-type currents are activated by voltages (Ϫ40 to Ϫ10 mV; cf. Gielow et al. 1995) slightly above the range of resting membrane potential values in the present work (Ϫ42 to Ϫ44 mV). Moreover, input resistance measurements reported here were elicited by hyperpolarizing rather than depolarizing pulses. Thus it seems unlikely that DPKQDFMRFa activates such L-type currents. These Drosophila muscles also contain amiloride-sensitive, T-like currents (Gielow et al. 1995) . However, DPKQDFMRFa-induced contractions are reduced by nifedipine but not sensitive to the T-type blockers amiloride and flunarizine (Clark et al. 2008) . Thus, although the postsynaptic effect of the peptide appears to be mediated by dihydropyridine-sensitive currents, the channels underlying such effects require further characterization. Other putative hormones, such as crustacean cardioactive peptide, proctolin, and DRNFLRFamide (Donini and Lange 2002; Nykamp et al. 1994; Quigley and Mercier 1997) , also require extracellular calcium to induce contractions in arthropod muscles. In addition, YIRFa elicits contractions and activates inward current in Fig. 9 . DPKQDFMRFa-induced sustained contractions are larger in cells 6 and 7 than in 12 and 13. A, No ablation: representative trace of 10 Ϫ7 M DPKQDFMRFa-induced contraction in semi-intact preparation with no cells ablated. A: 12&13 ablated and 6&7 ablated depict representative traces of peptide-mediated contractions in preparations with muscle cells 12 and 13 ablated and 6 and 7 ablated, respectively. B: doseresponse curve for the effect of DPKQDFMRFa on sustained contractions in intact preparations (no ablation). Note: the frequency and amplitude of the asynchronous, phasic contractions were not examined. C: the average change in tonus induced by DPKQDFMRFa is compared between preparations with no ablation with cells 12 and 13 ablated and with cells 6 and 7 ablated. Ablating both sets of cells (12 and 13, 6 and 7) significantly reduced the amplitude of peptide-induced sustained contractions compared with no-ablation controls (*P Ͻ 0.05). Peptide-induced contractions in preparations with cells 6 and 7 ablated were significantly lesser than those preparations with 12 and 13 ablated (*P Ͻ 0.05). muscles of the flatworm Schistosoma mansoni, and both effects are antagonized by inhibitors of L-type channels (Novozhilova et al. 2010) . These findings suggest that several peptide modulators may induce contractions in invertebrate muscles by activating calcium channels in the plasma membrane.
A 20 -25% decrease in input resistance, as observed in cells 6 and 7 during peptide exposure, would be expected to cause a proportional decrease in EJP amplitude if the synaptic current remained constant. Previous studies, however, demonstrated that DPKQDFMRFa increases synaptic current (Hewes et al. 1998) via an increase in the number of quanta of transmitter released per nerve impulse (Klose et al. 2010) . The overall increase in EJP amplitude in cells 6 and 7 would suggest that the magnitude of the increase in synaptic current exceeds the magnitude of the drop in input resistance. Indeed, 0.5-1 ϫ 10 Ϫ6 M DPKQDFMRFa was reported to increase synaptic current by 51-55% (Hewes et al. 1998; Klose et al. 2010) , which exceeds the magnitude of the drop in input resistance reported here. A 40% increase in the amplitude of compound EJPs is reported here for cells 6 and 7 in response to 1 ϫ 10 RNAi experiments previously showed that the ability of DPKQDFMRFa to increase synaptic current requires expression of FR and another peptide receptor, Drosophila myosuppressin receptor 2 (DmsR2), in Drosophila neurons (Klose et al. 2010) . Our results corroborate these findings by showing that the ability of the peptide to increase the size of compound EJPs requires FR expression in neurons. Reducing FR expression in muscle cells, however, had no significant effect on the ability of the peptide to increase EJP amplitude. These observations indicate that enhancement of EJPs by DPKQDFMRFa results primarily from presynaptic effects and that postsynaptic effects of the peptide contribute little (if anything) to the increase in EJPs. The small (23%) increase in EJP amplitude that persists following FR knockdown in neurons probably results from residual expression of FR and/or expression of DmsR2. FR expression was reduced by 60% in these larvae, but these measurements were made using whole larvae rather than isolated nervous systems. Thus, although RNAi successfully reduced FR expression, we have not estimated the degree of knockdown precisely in each tissue.
Although FR expression in muscle does not appear to contribute substantially to the enhancement of EJPs, it does contribute to the enhancement of muscle contraction. Knockdown of the FR in muscle cells caused a significant decrease in enhancement of nerve-evoked contractions by DPKQDFMRFa, and this reduction was similar to the effect of knocking down FR in nerve cells. Thus the ability of the peptide to increase the amplitude of nerve-evoked contractions involves presynaptic and postsynaptic mechanisms. The latter mechanisms are most likely reflected in the ability of DPKQDFMRFa to induce contractions, which are reduced by knocking down FR expression in muscle cells (Milakovic et al. 2014) . If the same postsynaptic mechanisms that induce contractions also contribute to the enhancement of nerve-evoked contractions, both modulatory effects should exhibit the same pattern of muscle cell specificity, at least to some extent (i.e., barring any overriding influence of presynaptic modulatory effects on transmitter output that could influence contractions of all 4 muscle cells). Indeed, cell ablation showed that muscle cells 6 and 7 contributed more than 12 and 13 to the ability of the peptide both to induce contractions and to enhance nerveevoked contractions. A similarity between the ability of DPKQDFMRFa to induce contractions and its enhancement of evoked contractions is also reflected in the dose dependence of the peptide. The EC 50 value for peptide-induced contractions (6.6 ϫ 10 Ϫ8 M) was only slightly higher than that reported previously for nerve-evoked contractions (2.5 ϫ 10 Ϫ8 M; Hewes et al. 1998) , and threshold for both effects was between 1 ϫ 10 Ϫ8 and 1 ϫ 10 Ϫ9 M ( Fig. 9B ; Clark et al. 2008; Hewes et al. 1998 ).
Higher FR expression in muscle cells 6 and 7 than in cells 12 and 13 (Fig. 10 ) correlated with larger contractions in 6 and 7 in the presence of DPKQDFMRFa (Figs. 7-9 ). However, cells 12 and 13 did contain mRNA for FR even though they showed no change in input resistance in response to DPKQDFMRFa (Fig. 2) . Thus our data indicate that the simple presence or absence of a receptor does not necessarily ensure that a particular modulatory effect will be observed. There could be several reasons for this such as cell-specific differences in posttranslational modification of the nascent receptor protein, turnover rates in the membrane, or rates of inserting the receptor into the plasma membrane. Although our data indicate that DmsR1 and DmsR2 do not contribute to the ability of DPKQDFMRFa to induce contractions, we have not ruled out the possibility that these receptors might contribute to other effects of this peptide such as reduction in input resistance.
We do not know which biochemical signaling pathways in the muscle cells give rise to peptide-induced contractions and/or peptide enhancement of evoked muscle contractions. Peptide-induced contractions require extracellular calcium and are antagonized by dihydropyridines (Clark et al. 2008 ) but do not appear to involve CaMKII, cAMP, cGMP, arachidonic acid, or linoleic acid, and the involvement of IP 3 and phospholipase C also seems unlikely (Milakovic et al. 2014) . They do, however, require FR expression in muscle cells and are sensitive to pertussis toxin, which confirms the involvement of this G protein-coupled receptor (Milakovic et al. 2014) . Presynaptic mechanisms through which DPKQDFMRFa enhances transmitter output and augments EJP amplitude include activation of at least two receptors (FR and DmsR2), release of calcium from internal stores, and activation of CaMKII (Dunn and Mercier 2005; Klose et al. 2010) . Thus presynaptic and postsynaptic modulatory effects of this neuropeptide appear to involve distinct intracellular signaling pathways. Octopamine has also been shown to elicit presynaptic and postsynaptic effects at neuromuscular junctions of locust (Evans 1981) and Drosophila (Ormerod et al. 2013 ) via distinct signaling systems.
The present results confirm that a neuropeptide can act directly on muscle fibers in a cell-selective manner, eliciting greater modulatory effects in some than in others. Although each muscle fiber in the Drosophila larval body wall is a single cell, each fiber acts as a separate muscle and is typically referred to as a muscle (e.g., Hoang and Chiba 2001) . This poses the question of whether our observations with Drosophila larvae represent cell specificity per se or whether they reflect selective modulation of different muscles. Previous work with the crab gastric mill (Jorge-Rivera et al. 1998) showed that aminergic and peptidergic modulators elicited differential effects on EJPs in two different muscles, gm4 and gm6, which might support the notion of muscle-specific modulation. That study reported differential effects on synaptic facilitation, which is modulated presynaptically (Zucker 1989) , and no attempt was made to examine postsynaptic effects directly. Thus differential effects on gastric mill muscles gm4 and gm6 (Jorge-Rivera et al. 1998 ) are likely to result from differential effects on the motor nerve terminals. GABA, however, can also act as a selective modulator on gastric mill muscles of the lobster, acting presynaptically via GABA A -like receptors to enhance excitatory transmission onto three muscles (gm6a, gm9, and p1) and acting postsynaptically via GABA B -like receptors to increase conductance in muscles gm6a and gm9 but not in muscle p1 (Gutovitz et al. 2001) . Thus muscles can be modulated selectively by postsynaptic mechanisms even when they share common presynaptic modulatory effects. Cell-selective modulation within one muscle has been reported for octopamine, which increases cAMP levels to a greater extent in tonic and intermediate fibers of locust extensor tibiae muscle than in phasic fibers of the same muscle (Evans 1985) . These observations support the notion that cell-selective modulation within a given muscle may be related to tonic vs. phasic fiber types. Octopamine also increases both EJPs and evoked contractions more strongly in Drosophila larval muscles 12 and 13 than 6 and 7, and it can induce contractions directly (Ormerod et al. 2013) . Thus octopamine appears to be capable of modulating individual muscle cells selectively via a direct action in addition to whatever presynaptic effects it may elicit.
Functional implications of fiber-selective and muscle-selective modulation by peptidergic and aminergic neurohormones are not yet known. Selective enhancement of contractions of tonic or phasic muscle fiber types could play an important role during activation of slow or fast movements in arthropods, which exhibit great diversity of contractile properties both within and between muscles (Atwood 1976; Atwood et al. 1965; Gunzel et al. 1993) . Indeed, inhibition of tonic fibers in a given muscle is thought to reduce "drag" during movements generated by faster fibers (Ballantyne and Rathmayer 1981; Wiens 1989) . It is interesting that DPKQDFMRFa modulates Drosophila muscle cells 6 and 7 to a greater extent than 12 and 13, whereas octopamine has the opposite effect (Ormerod et al. 2013) . This suggests that different modulators may have complementary functions in the peripheral nervous system, potentiating synaptic transmission and contraction more at different subsets of muscles or muscle cells. Such differential modulation might play a role in locomotion in Drosophila larvae such as enhancing the contraction of medial muscle cells during forward movement and enhancing contraction of lateral muscle cells during turning. Interestingly, proctolinergic nerve terminals are found on muscle 4 (which is located laterally) and muscles 12 and 13 (which are lateral to 6 and 7) but not on the most medial muscles, 6 and 7 (Anderson et al. 1988) . Our findings also open the question of whether modulation within the CNS, to elicit selected motor output patterns, is matched by peripheral modulation of selected muscle cells and the motor nerve terminals on them. Cell-selective modulation in the peripheral and CNS may help to account for the presence of so many peptidergic signaling molecules.
